Democritus University of Thrace (DUTH)
Εκτίμηση των επιπέδων της 25-υδρόξυ βιταμίνης D του ορού σε μεγάλο δείγμα πληθυσμού της περιφέρειας Ανατολικής Μακεδονίας και Θράκης και συσχέτιση με παθολογικές καταστάσεις
Abstract
dc:descriptionVitamin D is a fat-soluble prohormone with a key role in calcium–phosphorus homeostasis and skeletal health, while also demonstrating broader pleiotropic actions across multiple human systems. It is synthesized mainly in the skin from 7-dehydrocholesterol under UVB radiation, producing cholecalciferol (D3). It is then hydroxylated sequentially in the liver to 25-hydroxyvitamin D [25(OH)D] and in the kidneys to 1,25-dihydroxyvitamin D [1,25(OH)₂D], the biologically active form of vitamin D. The most reliable indicator of vitamin D status is 25(OH)D, with a half-life of 2–3 weeks. By contrast, 1,25(OH)₂D does not adequately reflect vitamin D stores because it has a half-life of <4 hours, circulates at much lower concentrations, and is tightly regulated by PTH and calcium/phosphorus levels. The active form acts via the nuclear vitamin D receptor (VDR), which is expressed not only in the intestine, bone, and kidneys but also in hematopoietic and immune cells, the myocardium, brain, skeletal/smooth muscle, liver, breast, prostate, skin, and endocrine glands—accounting for systemic effects. Beyond classical skeletal actions, 25(OH)D deficiency has been associated with higher risk of infections, autoimmune and neurological diseases, cardiometabolic disorders, and malignancies. The aim of this study was to accurately assess 25-hydroxyvitamin D levels in a large population sample from Eastern Macedonia & Thrace and to investigate their relationship with specific pathological conditions and lifestyle factors. The study had an observational design and included two distinct subsets during 2018–2024: 2000 hospitalized patients from all clinical departments of the University General Hospital of Alexandroupolis and 600 adults without serious underlying disease (blood donors, outpatient clinics, preventive screening), who also completed the study questionnaire. Serum 25(OH)D was measured using a standardized radioimmunoassay (RIA, DiaSorin) following acetonitrile extraction, with calibrators and control materials, according to the manufacturer’s specifications. Vitamin D status was defined as deficiency <20 ng/mL, insufficiency 20–29 ng/mL, and sufficiency ≥30 ng/mL, extreme values were predefined as ≤10 and ≥50 ng/mL. Strict exclusion criteria were applied, and the protocol was aligned with the Declaration of Helsinki and GDPR. The main findings were as follows. First, hospitalized patients exhibited significantly lower 25(OH)D levels than the healthy population and a much higher prevalence of deficiency, which may indicate a strong association between hypovitaminosis D and various underlying diseases. Second, a pronounced seasonal variation was observed in both subsets (ANOVA p<0.001), with lower values in winter and higher in summer. Third, there was an inverse association between age and 25(OH)D: among those >65 years, deficiency was more frequent and sufficiency rare, whereas younger groups—especially <40 years—showed higher levels and a greater probability of sufficiency. Additionally, sex differences were present but of small effect size. Finally, in the general population the decisive role of sun exposure and behavioral factors was highlighted, alongside an inverse relationship with BMI. In summary, this study documents a high burden of hypovitaminosis D among hospitalized patients, especially those with chronic kidney disease, COVID-19, oncological and autoimmune diseases, as well as consistent seasonality of 25(OH)D levels. The conclusions support targeted screening and supplementation in high-risk groups, education for safe yet adequate sun exposure, and the incorporation of 25(OH)D assessment into the management of chronic diseases.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pistola, Anastasia
- Πιστόλα, Αναστασία
Subjects
dc:subject × 19- Βιταμίνη D
- 25(OH)D
- Ραδιοανοσολογική μέθοδος (RIA)
- Υποκείμενα νοσήματα
- Vitamin D
- Radioimmunoassay (RIA)
- Underlying medical conditions
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Βασική ιατρική, γενικά
- Κλινική Ιατρική
- Κλινική ιατρική, γενικά
- Γενική και Εσωτερική ιατρική
- Basic Medicine
- Medical and Health Sciences
- Basic medicine, general
- Clinical Medicine
- Clinical medicine, general
- General and Internal Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60224